Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.31 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.31 |
| ▸ | TDO2 | P48775 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13615922 | 1.00 | PARP1 (0.31) | PARP1CSNK2A1MAP4K4TDO2ALDH1A1 | |
| SCHEMBL13615949 | 1.00 | PARP1 (0.31) | PARP1CSNK2A1MAP4K4TDO2ALDH1A1 | |
| SCHEMBL13615873 | 0.92 | MAP4K4 (0.30) | MAP4K4 | |
| SCHEMBL17229027 | 0.90 | PARP1 (0.33) | PARP1CSNK2A1MAP4K4TDO2 | |
| SCHEMBL30340690 | 0.90 | PARP1 (0.33) | PARP1CSNK2A1MAP4K4TDO2 | |
| SCHEMBL17229032 | 0.90 | PARP1 (0.33) | PARP1CSNK2A1MAP4K4TDO2 | |
| SCHEMBL17229024 | 0.90 | PARP1 (0.33) | PARP1CSNK2A1MAP4K4TDO2 | |
| SCHEMBL17691999 | 0.85 | ALDH1A1 (0.35) | TDO2ALDH1A1HPGDHSD17B10 | |
| SCHEMBL20698477 | 0.85 | TDO2 (0.33) | MAP4K4TDO2ALDH1A1CYP1A2HPGD | |
| SCHEMBL13615763 | 0.85 | CLK4 (0.39) | PARP1CSNK2A1ALDH1A1CYP1A2THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, ORMDL3 | PARP1 2175/4885CSNK2A1 3466/4885MAP4K4 3602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.